Tampe, B., Tampe, D., Zeisberg, E. M., Müller, G. A., Bechtel-Walz, W., Koziolek, M., . . . Zeisberg, M. (2014). Induction of Tet3-dependent Epigenetic Remodeling by Low-dose Hydralazine Attenuates Progression of Chronic Kidney Disease. EBioMedicine.
Chicago-stil citatTampe, Björn, Desiree Tampe, Elisabeth M. Zeisberg, Gerhard A. Müller, Wibke Bechtel-Walz, Michael Koziolek, Raghu Kalluri, och Michael Zeisberg. "Induction of Tet3-dependent Epigenetic Remodeling By Low-dose Hydralazine Attenuates Progression of Chronic Kidney Disease." EBioMedicine 2014.
MLA-referensTampe, Björn, et al. "Induction of Tet3-dependent Epigenetic Remodeling By Low-dose Hydralazine Attenuates Progression of Chronic Kidney Disease." EBioMedicine 2014.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.